A novel in situ gel for sustained drug delivery and targeting.
The objective of this study was to develop a novel chitosan-glyceryl monooleate (GMO) in situ gel system for sustained drug delivery and targeting. The delivery system consisted of 3% (w/v) chitosan and 3% (w/v) GMO in 0.33M citric acid. In situ gel was formed at a biological pH. In vitro release studies were conducted in Sorensen's phosphate buffer (pH 7.4) and drugs were analyzed either by HPLC or spectrophotometry. Characterization of the gel included the effect of cross-linker, determination of diffusion coefficient and water uptake by thermogravimetric analysis (TGA). Mucoadhesive property of the gel was evaluated in vitro using an EZ-Tester. Incorporation of a cross-linker (glutaraldehyde) retarded the rate and extent of drug release. The in vitro release can further be sustained by replacing the free drug with drug-encapsulated microspheres. Drug release from the gel followed a matrix diffusion controlled mechanism. Inclusion of GMO enhanced the mucoadhesive property of chitosan by three- to sevenfold. This novel in situ gel system can be useful in the sustained delivery of drugs via oral as well as parenteral routes.
Ganguly
Sudipta
S
Department of Pharmacy Sciences, School of Pharmacy and Health Professions, Creighton University, 2500 California Plaza, Omaha, NE 68178, USA.
Dash
Alekha K
AK
D000779:Anesthetics, Local / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D001672:Biocompatible Materials / Q000737:chemistry; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D002686:Chitin / Q000031:analogs & derivatives* / Q000737:chemistry*; D048271:Chitosan; D003432:Cross-Linking Reagents / Q000737:chemistry*; D003907:Dexamethasone / Q000737:chemistry*; D016503:Drug Delivery Systems; D005782:Gels; D005976:Glutaral / Q000737:chemistry*; D005990:Glycerol / Q000737:chemistry*; D007660:Ketoprofen / Q000008:administration & dosage*; D008012:Lidocaine / Q000008:administration & dosage*; D008863:Microspheres
D000779:Anesthetics, Local; D000935:Antifungal Agents; D001672:Biocompatible Materials; D003432:Cross-Linking Reagents; D005782:Gels; D002686:Chitin; D003907:Dexamethasone; D048271:Chitosan; D007660:Ketoprofen; D008012:Lidocaine; D005990:Glycerol; D005976:Glutaral